Related Experiment Video
Updated: Aug 23, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Postoperative nesiritide use following high-risk mitral valve replacement
John W C Entwistle1, David E McLoughlin, Kourosh Baghelai
1Department of Cardiothoracic Surgery, Drexel University College of Medicine, Hahnemann University Hospital, Philadelphia, Pennsylvania 19102, USA.
Abstract:
Nesiritide is primarily used in the treatment of acutely decompensated chronic heart failure. It may also be useful in the postoperative management of patients with an exacerbation of heart failure after cardiac surgery. The management of a patient with cardiogenic shock after acute papillary muscle rupture is described. The patient exhibited signs of postoperative heart failure, and nesiritide therapy was instituted to lower filling pressures and achieve diuresis. This drug may be useful when patients with heart failure undergo cardiac surgery and continue to show evidence of heart failure in the postoperative period.
Related Concept Videos
Mitral Stenosis IV: Nursing Management
Mitral Regurgitation IV: Nursing Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse III: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
